Kolosis Announces the Appointment of Jason May as Area Vice President, Southeast
Kolosis announced today the appointment of Jason May as Area Vice President, Southeast. Prior to joining Kolosis, Jason held leadership roles at Globus where he managed a team of over 25 managers and sales specialists responsible for $45 million annually. For the 6 years prior to his time with Globus, Jason was a Regional Manager […]
MTF Biologics and Kolosis BIO Launch the Latest Addition to the DBX Family: DBX Fiber®
EDISON, N.J. & SALT LAKE CITY–(BUSINESS WIRE)–MTF Biologics, a global nonprofit organization that saves and heals lives by advancing tissue and organ donation, transplantation, and research, and Kolosis®, an industry leading pure-play surgical biologics company, today announced the launch of DBX Fiber®, the latest addition to the DBX® family. For decades, DBX has been a […]
Kolosis BIO® Expands Surgical Biologics Portfolio with Launch of APEXecm™
Salt Lake City, Utah — Kolosis®, the industry’s leading pure-play surgical biologics company, today announced the addition of APEXecm™ to its growing portfolio of targeted solutions. The launch reflects Kolosis’s approach to portfolio expansion — identifying technologies that address unmet clinical needs and delivering them with the commercial focus and technical expertise that only a […]
Kolosis Attends 2026 Spine Summit
The Kolosis team will be attending the 2026 Spine Summit in Phoenix, Arizona. The Spine Summit meeting is a world-class program featuring industry-leading experts, hands-on workshops and the latest advancements in spinal care. This annual event is hosted by AANS (American Association of Neurological Surgeons), and connects top professionals with experts in the field. Kolosis […]
Kolosis Attends 2026 Life Sciences Day on the Hill at the Utah State Capitol
Kolosis was honored to attend the 2026 Life Sciences Day on the Hill event at the Utah State Capitol this week. The Kolosis team hosted a booth and showcased their innovative biologics to legislators and other biotech companies headquartered in Utah. This event features exhibits from local life science companies in the capitol rotunda. This […]
Kolosis Attends 2026 STS Annual Meeting
The Kolosis team will be attending the 2026 STS (Society of Thoracic Surgeons) Annual Meeting in New Orleans, Louisiana. The STS Annual Meeting is a premier event in cardiothoracic surgery, featuring cutting-edge education, scientific research, and interdisciplinary collaboration. This annual meeting brings together leading surgeons, clinicians, and industry experts to explore emerging trends, innovations, and […]
MTF Biologics and Kolosis BIO Launch New Solution for Orthopedic and Spinal Surgeries: Summit Matrix™
EDISON, N.J. & SALT LAKE CITY– MTF Biologics, a global nonprofit organization that saves and heals lives by advancing tissue and organ donation, transplantation, and research, and Kolosis BIO (Kolosis), a premier provider of orthobiologic solutions, today announced the launch of Summit Matrix™, an advanced synthetic bone graft designed to improve bone regeneration after orthopedic […]
Kolosis Announces Strong 2025 Results
In 2025, we grew revenue by 60% year over year Delivered >$55M in revenue while taking serious market share Added 4 products to our portfolio (ATLAS, IKON, DBX, Summit Matrix) Our grafts are on shelf in facilities across all 50 states Kolosis grafts are approved in over 5,800 facilities across the country Kolosis bone grafts […]
Kolosis Recognized as a Fastest Growing Company by Utah Business Magazine
Salt Lake City, UT — Kolosis is proud to announce that they have been awarded 8th place on Utah Business magazine’s 2025 Fast 50 list of the state’s fastest-growing companies. The Fast 50 recognizes Utah companies five years or older that demonstrate both high revenue growth and strong overall revenue performance. This marks the third consecutive […]
MTF Biologics and Kolosis BIO Launch Two New Allografts to Advance Cardiac Surgery
(BUSINESS WIRE) MTF Biologics, a global nonprofit organization that saves and heals lives by advancing tissue and organ donation, transplantation, and research, and Kolosis BIO (Kolosis), a premier provider of biologic solutions, today announced they have partnered to bring two innovative allograft tissues to cardiac surgeons: ATLAS™ Sternal Repair Matrix for sternal fusion and IKON™ […]